Cart
sales@molnova.com
Home -
Products -
Others -
Other Targets -
Piperazine, 1-(4-fluorophenyl)-4-[(3,4,5-trimethoxyphenyl)methyl]-
Piperazine, 1-(4-fluorophenyl)-4-[(3,4,5-trimethoxyphenyl)methyl]-
CAS No. 80305-11-9
Piperazine, 1-(4-fluorophenyl)-4-[(3,4,5-trimethoxyphenyl)methyl]-( —— )
Catalog No. M28945 CAS No. 80305-11-9
Piperazine, 1-(4-fluorophenyl)-4-[(3,4,5-trimethoxyphenyl)methyl]- is a piperazine derivative.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 101 | Get Quote |
|
| 10MG | 143 | Get Quote |
|
| 25MG | 234 | Get Quote |
|
| 50MG | 347 | Get Quote |
|
| 100MG | 516 | Get Quote |
|
| 500MG | 1125 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePiperazine, 1-(4-fluorophenyl)-4-[(3,4,5-trimethoxyphenyl)methyl]-
-
NoteResearch use only, not for human use.
-
Brief DescriptionPiperazine, 1-(4-fluorophenyl)-4-[(3,4,5-trimethoxyphenyl)methyl]- is a piperazine derivative.
-
DescriptionPiperazine, 1-(4-fluorophenyl)-4-[(3,4,5-trimethoxyphenyl)methyl]- is a piperazine derivative.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorPHGDH
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number80305-11-9
-
Formula Weight360.42
-
Molecular FormulaC20H25FN2O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOC1=CC(CN2CCN(CC2)C2=CC=C(F)C=C2)=CC(OC)=C1OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Wang Q, et al. Rational Design of Selective Allosteric Inhibitors of PHGDH and Serine Synthesis with Anti-tumor Activity. Cell Chem Biol. 2017 Jan 19;24(1):55-65.
molnova catalog
related products
-
Pongamol
Pongamol, an identified lead molecule from the fruits of Pongamia pinnata, on glucose uptake and GLUT4 translocation in skeletal muscle cells.
-
Tetraethylene glycol...
Tetraethylene glycol monooctyl ether is a nonionic nonionic surfactant.
-
Arundic Acid
Arundic Acid is an astrocyte-modulating agent, delays the expansion of cerebral infarcts by modulating the activation of astrocytes through inhibition of S-100β synthesis.
